SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001144204-17-026886
Filing Date
2017-05-12
Accepted
2017-05-12 16:01:28
Documents
9
Effectiveness Date
2017-05-12

Document Format Files

Seq Description Document Type Size
1 DEFM14A v466775_defm14a.htm DEFM14A 3650141
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_craig-hallum.jpg GRAPHIC 81327
4 GRAPHIC logo_transgenomic.jpg GRAPHIC 49681
5 GRAPHIC sig_craighallum-capgroup.jpg GRAPHIC 36151
6 GRAPHIC sig_paul-kinnon.jpg GRAPHIC 20959
7 GRAPHIC spacer.gif GRAPHIC 43
8 GRAPHIC v466775_pc1.jpg GRAPHIC 1008725
9 GRAPHIC v466775_pc2.jpg GRAPHIC 643287
  Complete submission text file 0001144204-17-026886.txt   6185960
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-36439 | Film No.: 17838457
SIC: 3826 Laboratory Analytical Instruments